Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inhibikase Therapeutics, Inc.

1.84
-0.0600-3.16%
Post-market: 1.890.0500+2.72%19:49 EDT
Volume:94.03K
Turnover:174.79K
Market Cap:136.79M
PE:-2.24
High:1.92
Open:1.92
Low:1.83
Close:1.90
Loading ...

Inhibikase Therapeutics Approves Key Proposals at Annual Meeting

TIPRANKS
·
01 Jul

Inhibikase Therapeutics Inc. Concluded Annual Stockholder Meeting

Reuters
·
01 Jul

Ludwig Enterprises Inc. Appoints Garth Lees-Rolfe as New Independent Director

Reuters
·
26 Jun

BRIEF-Inhibikase Therapeutics files for mixed shelf of up to $300 mln

Reuters
·
21 Jun

Inhibikase Therapeutics files $300M mixed securities shelf

TIPRANKS
·
21 Jun

Inhibikase Therapeutics : Sales Agreement Prospectus Covering Offering of up to $200 Mln Common Stock That May Be Issued From Time to Time

THOMSON REUTERS
·
21 Jun

Inhibikase Therapeutics Inc Files for Mixed Shelf of up to $300 Mln – SEC Filing

THOMSON REUTERS
·
21 Jun

Inhibikase Therapeutics Reports Q1 2025 Financial Results

TIPRANKS
·
23 May

Inhibikase Therapeutics: Strategic Realignment and Financial Strength Justify Buy Rating

TIPRANKS
·
16 May

Inhibikase Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
15 May

Inhibikase Therapeutics Inc expected to post a loss of 10 cents a share - Earnings Preview

Reuters
·
15 May

Inhibikase Therapeutics Reports $13.7M Net Loss in Q1 2025, EPS at $0.15

Reuters
·
15 May

Inhibikase Therapeutics Inc expected to post a loss of 10 cents a share - Earnings Preview

Reuters
·
10 May

BRIEF-Q32 Bio Inc - Mark Iwicki Resigns From Q32 Bio Board Effective Dec 31, 2025

Reuters
·
26 Apr

Q32 Bio Inc - Iwicki Resigns to Focus on CEO Role at Inhibikase Therapeutics

THOMSON REUTERS
·
26 Apr

Q32 Bio Inc - Mark Iwicki Resigns From Q32 Bio Board Effective Dec 31, 2025

THOMSON REUTERS
·
26 Apr

BRIEF-Inhibikase Therapeutics Announces Appointment Of David Mcintyre As CFO

Reuters
·
14 Apr

Inhibikase Names McIntyre Finance Chief as Lees-Rolfe Resigns

Dow Jones
·
14 Apr

Inhibikase Therapeutics announces appointment of McIntyre as CFO

TIPRANKS
·
14 Apr

Press Release: Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer

Dow Jones
·
14 Apr